Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: GREG FINLEY who wrote (411)	11/22/1999 9:46:00 PM
From: geewiz	Respond to of 534

Hello Greg, I do check the postings on YHOO every week or so. Just don't have time to follow closely. Here is one more new competitor; INTRAJECT is a disposable injection device the size of a pen,which comes pre-filled and ready to use. Its special design enables liquid medicines to be administered through the skin and without the need for needles. No preparation or special training is required. The device consists of a tiny power source of compressed nitrogen gas and a revolutionary drug capsule which holds the medication. To use INTRAJECT, the patient simply places the device on their skin and by applying light pressure the medicine is released. The whole injection process is over in about a quarter of a second and feels like flicking your skin with your fingertip. It is so easy to use that patients should be able to use the device to inject themselves at home. weston-medical.com weston-medical.com later, art

To: GREG FINLEY who wrote (411)	11/23/1999 8:08:00 PM
From: geewiz	Read Replies (1) \| Respond to of 534

Greg, all, here's an interesting article, although 13 months old it ties up several partners BJCT has had dealings with (Vical and Navy research); New DNA vaccine promotes immune response in some people October 15, 1998 Web posted at: 4:40 p.m. EDT (2040 GMT) From Medical Correspondent Elizabeth Cohen ATLANTA (CNN) -- In abreakthrough discovery, Navy researchers have used a vaccine containing DNA to help prevent malaria. A team from the Naval Medical Research Center in Bethesda, Maryland, announced Thursday that its scientists have tested the DNA vaccine in healthy humans with some success. The research team's study is the first published article demonstrating that a DNA vaccine can elicit an immune response in healthy humans. The Navy researchers gave the vaccine to 20 healthy people. Eleven developed an immune response to malaria, according to the Navy's Dr.William Rogers. However, researchers said this immune response would probably not be enough to protect the subjects from getting malaria. The hope is that a more potent vaccine -- to be tested next year -- would keep people from getting ill. Robert Zaugg, vice-president of Vical Inc., the company that makes the malaria vaccine used in the study said a malaria DNA vaccine could be on the market in the year 2005 at the earliest. The vaccine includes genes found in the DNA of malaria that are then injected into people. Muscle cells then absorb the DNA and cells start releasing proteins that trigger an immune response that scientist hope will protect from malaria. copywrite CNN Interactive I found it on the DNA Vaccine website; cnn.com later,art